Skip to content

The effects of remimazolam and dexmedetomidine on emotion, cognitive function, and neuroprotection in patients with ischemic stroke

Clinical effects of remimazolam and dexmedetomidine on emotion, cognitive function, and neuroprotection in patients with ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN28704245
Enrollment
72
Registered
2026-04-20
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with ischemic stroke Circulatory System

Interventions

1. Preoperative Assessment (24 h Before Surgery) Anxiety and depression were evaluated using HADS-A and HADS-D. Cognitive function was assessed by MoCA and MMSE. Neurological impairment was scored wit
maintenance with remimazolam 0.2–0.5 mg·kg?¹·h?¹ (BIS 40–60), discontinued 30 min before surgery. Group Dex: Loading dose of dexmedetomidine 0.5 µg/kg iv 10 min before induction
maintenance with 0.2 µg·kg?¹·h?¹ (BIS 40–60), discontinued 30 min before surgery. Group C: Routine propofol-based anesthesia without remimazolam or dexmedetomidine. Anesthesia induction: Propofol 2–3
orotracheal intubation (depth 22–24 cm) followed by mechanical ventilation (FiO2 30%, RR 10–12 breaths/min, I:E 1:2–2.5, VT 8–12 mL/kg, ETCO2 35–45 mmHg). Anesthesia maintenance: Propofol 4–12 mg·kg?¹
additional sufentanil 0.2 µg/kg before skin incision
BIS maintained at 40–60, with dosage adjusted according to vital signs. Fluid therapy included lactated Ringer’s solution and 6% hydroxyethyl starch. Anesthesia emergence: Neuromuscular blockade rever

Sponsors

People's Hospital of Xinjiang Uygur Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of acute anterior circulation ischemic stroke (internal carotid artery / M1–M2 segment of middle cerebral artery), with penumbra confirmed by CTP/MRP 2. Age 18–80 years, no gender restriction, ASA physical status I–III 3. Admission within 24 hours of symptom onset 4. NIHSS score 4–15 (mild-to-moderate neurological injury[7]), mRS score =4 5. No preoperative history of anxiety/depression (HADS score =7) or cognitive impairment (MoCA =26, MMSE =24) 6. Prior to the study, the patient or legal representative understood and voluntarily signed the informed consent approved by the ethics committee, agreed to randomization, and cooperated with follow-up

Exclusion criteria

Exclusion criteria: 1. Diagnosis of global aphasia, transient ischemic attack, visual or auditory impairment, or severe dementia (MMSE 70 mL); complicated with intracranial hemorrhage (type PH2 hematoma) or mass effect 9. Anesthesia-related exclusion: difficult airway, severe intraoperative hypotension (MAP 10 minutes), or requirement for high-dose vasoactive drugs

Countries

China

Contacts

Public ContactNan Chen
13579202240@163.com-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 7, 2026